Meta Platforms Stock News

Facebook parent Meta crashed on weak earnings and guidance. Spotify also dived. Tech futures sold off after a narrow market rally.

Meta, the company that owns Facebook, Instagram and WhatsApp, saw its stock plunge after-hours Wednesday after reporting a rare decline in its fourth quarter profit due to a sharp increase in expenses

When Facebook sneezes, social media catches a cold: Social media stocks are crumbling postmarket in the wake of heavy disappointment in the report from Facebook parent Meta

Meta Platforms Inc (NASDAQ: FB ) will likely post rising revenues in Q4 2021 but a modest decline in profit as it ramps up metaverse spending, the Wall Street Journal notes . Meta will also break out its Reality Labs segment, which will offer investors insight into the health of the virtual Full story available on Benzinga.com

It only took Libra/Diem two years to come full circle from publishing its white paper to falling apart.

The virtual worlds that currently exist are barren and awkward, but they still exist and are further along than what Meta has created.

Here are Wednesday''s biggest Wall Street calls.

Facebook (FB), now known as Meta Platforms, steps up to the plate after the close on Wednesday in the next of the mega tech names to report earnings.

Indian officials have held heated discussions with Google, Twitter and Facebook for not proactively removing what they described as fake news on their platforms

US Stocks: ELLIOTT WAVE ANALYSIS Tesla (TSLA) Amazon (AMZN) Apple (AAPL) Alphabet (GOOGL) Facebook (FB) Meta Platforms (META) Microsoft (MSFT) JPMorgan

facebook messenger screenshot

Dorsey said that although Facebook probably started Diem for the right reasons, it shouldve used an open-ended protocol like Bitcoin rather than attempting to create its own currency.

Taibbi: The British Medical Journal Story That Exposed Politicized "Fact-Checking" Authored by Matt Taibbi via TK News , In February of 2010, the New York Times released a front-page story entitled, Research Ties Diabetes Drug to Heart Woes . The lede read: Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market. The Times piece quoted an internal F.D.A. report that said the GlaxoSmithKline diabetes drug Avandia, also known as Rosiglitazone, was linked to 304 deaths in 2009, adding the conclusion of the two doctors who authored the report: Rosiglitazone should be removed from the market. The story was released in advance of a Senate Finance Committee study that produced a series of damning internal documents, including one in which an FDA safety officer expressed concern that Avandia presented such serious cardiovascular risks that the safety of the study itself cannot be assured, and is not acceptable. One of the chief investigators on that study was Paul Thacker, at the time a committee aide under Iowa Republican Chuck Grassley.

Meta Platforms/Facebook (NASDAQ:FB) is scheduled to announce Q4 earnings results on Wednesday, February 2nd, after market close.The consensus EPS Estimate is $3.83 (-1.3% Y/Y) and

FB stock metrics are bulletproof. So, by investors should be looking for entry spots on dips, especially from bad earnings reactions.